Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia

ABSTRACT: An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia

PROVIDER: PRJNA768862 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR16209000_1.fastq.gz	Fastqsanger.gz
	SRR16209000_2.fastq.gz	Fastqsanger.gz
	SRR16209001_1.fastq.gz	Fastqsanger.gz
	SRR16209001_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 185

Similar Datasets

An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia

Project description:An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia

| PRJNA895072 | ENA

An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia

Project description:Acute myeloid leukemia (AML) is a hematopoietic malignancy with poor prognosis and limited treatment options. Here we provide a comprehensive census of the bone marrow immune microenvironment in adult and pediatric AML patients. We characterize unique inflammation signatures in a subset of AML patients, associated with inferior outcomes. We identify atypical B cells, a dysfunctional B cell subtype enriched in high-inflammation AML patients, as well as an increase in CD8+ GZMK+ and regulatory T cells, accompanied by a reduction in T cell clonal expansion. We derive an inflammation-associated gene score (iScore) that associates with poor survival outcomes in AML patients. Addition of the iScore refines current risk stratifications for AML patients and may enable identification of patients in need of more aggressive treatment. This work provides a framework for classifying AML patients based on their immune microenvironment and a rationale for consideration of the inflammatory state in clinical settings.

2022-11-04 | GSE185381 | GEO

An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia

Project description:Acute myeloid leukemia (AML) is a hematopoietic malignancy with poor prognosis and limited treatment options. We characterize unique inflammation signatures in a subset of AML patients, and derive an inflammation-associated gene score (iScore) that associates with poor survival outcomes in AML patients. The addition of the iScore refines current risk stratifications for AML patients and may enable the identification of patients in need of more aggressive treatment. This work provides a framework for classifying AML patients based on their immune microenvironment and a rationale for consideration of the inflammatory state in clinical settings. This submission represents the adult RNA-Seq component of study.

2022-11-01 | GSE216738 | GEO

An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia.

Project description:Acute myeloid leukemia (AML) is a hematopoietic malignancy with poor prognosis and limited treatment options. Here we provide a comprehensive census of the bone marrow immune microenvironment in adult and pediatric patients with AML. We characterize unique inflammation signatures in a subset of AML patients, associated with inferior outcomes. We identify atypical B cells, a dysfunctional B-cell subtype enriched in patients with high-inflammation AML, as well as an increase in CD8+GZMK+ and regulatory T cells, accompanied by a reduction in T-cell clonal expansion. We derive an inflammation-associated gene score (iScore) that associates with poor survival outcomes in patients with AML. Addition of the iScore refines current risk stratifications for patients with AML and may enable identification of patients in need of more aggressive treatment. This work provides a framework for classifying patients with AML based on their immune microenvironment and a rationale for consideration of the inflammatory state in clinical settings.

| S-EPMC9986885 | biostudies-literature

Endometrial cancer risk stratification

Project description:Endometrial cancer (ENDOM) prevention remains challenging, creating an urgent need for better risk stratification tools. We developed a prompt-based bimodal multilevel endometrial cancer (2M-EC) predictive platform that integrates clinically accessible data with multi-biofluid molecular profiles through MALDI-TOF MS analysis. Our study established the MBF-ED cohort (n=531), collecting comprehensive clinical data and multi-dimensional body fluid samples. We processed these using a unique analytical pipeline: (1) simplifying clinical variables through empirical and data-driven methods, (2) extracting ENDOM-specific MS features using machine learning, and (3) developing an innovative bimodal AI architecture that fuses 2D MS omics matrices with 1D clinical vectors. The resulting prompt-based 2M-EC predictive platform provides real-time, interpretable risk stratification through an online interface. The advantages of it include overcoming single-marker limitations via multimodal integration, combining molecular depth with clinical practicality and scalable design adaptable to both resource-limited and advanced healthcare settings. This work demonstrates how AI can bridge cutting-edge molecular profiling with routine clinical practice, offering a new paradigm for task-oriented cancer risk assessment.

2025-04-22 | PXD063211 |

Myeloid ROS remodels pulmonary microenvironment to protect lungs from acute lung injury

Project description:Myeloid ROS remodels pulmonary microenvironment to protect lungs from acute lung injury

| PRJNA554905 | ENA

A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy

Project description:To determine whether adding Decipher to standard risk stratification tools (CAPRA-S and Stephenson nomogram) improves accuracy in prediction of metastatic disease within 5 years after surgery in men with adverse pathologic features after RP.

2014-11-21 | GSE62667 | GEO

Farnesyl diphosphate synthase inhibition remodels the tumor immune microenvironment by activating endogenous retroviruses

Project description:Farnesyl diphosphate synthase inhibition remodels the tumor immune microenvironment by activating endogenous retroviruses

| PRJEB82515 | ENA

Farnesyl diphosphate synthase inhibition remodels the tumor immune microenvironment by activating endogenous retroviruses

Project description:Farnesyl diphosphate synthase inhibition remodels the tumor immune microenvironment by activating endogenous retroviruses

| PRJEB82516 | ENA

Chemohormonal Therapy Remodels Prostate Cancer Immune Microenvironment and Enhances Checkpoint Inhibitor-based immunotherapy

Project description:Chemohormonal Therapy Remodels Prostate Cancer Immune Microenvironment and Enhances Checkpoint Inhibitor-based immunotherapy

| PRJNA798366 | ENA